TCM
Tang Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.4M | Hold |
2,454,797
| – | – | 5.03% | 2 |
|
|
2025
Q1 | $126M | Buy |
2,454,797
+200,000
| +9% | +$10.3M | 6.98% | 1 |
|
|
2024
Q4 | $125M | Hold |
2,254,797
| – | – | 8.26% | 1 |
|
|
2024
Q3 | $74.2M | Hold |
2,254,797
| – | – | 5.3% | 2 |
|
|
2024
Q2 | $61.3M | Hold |
2,254,797
| – | – | 6.24% | 1 |
|
|
2024
Q1 | $82M | Buy |
2,254,797
+50,000
| +2% | +$1.82M | 8.53% | 1 |
|
|
2023
Q4 | $44.6M | Buy |
2,204,797
+64,211
| +3% | +$1.3M | 4.13% | 3 |
|
|
2023
Q3 | $38M | Buy |
2,140,586
+361,428
| +20% | +$6.42M | 5.37% | 1 |
|
|
2023
Q2 | $32.1M | Sell |
1,779,158
-255,000
| -13% | -$4.61M | 4.73% | 2 |
|
|
2023
Q1 | $25.6M | Buy |
2,034,158
+32,573
| +2% | +$409K | 3.81% | 5 |
|
|
2022
Q4 | $29.3M | Sell |
2,001,585
-88,271
| -4% | -$1.29M | 4.26% | 4 |
|
|
2022
Q3 | $35.8M | Buy |
2,089,856
+5,486
| +0.3% | +$93.9K | 4.39% | 4 |
|
|
2022
Q2 | $30.4M | Buy |
2,084,370
+1,784,370
| +595% | +$26.1M | 4.62% | 7 |
|
|
2022
Q1 | $5.05M | Buy |
+300,000
| New | +$5.05M | 1.01% | 29 |
|